SCHEMBL14764263

SCHEMBL14764263

Nc1ccc(CN2CC3(COC3)C2)cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 1/20 0.39
TLR7 Q9NYK1 1/20 0.39
GABRP O00591 1/20 0.38
GABRD O14764 1/20 0.38
GABRA1 P14867 1/20 0.38
GABRB1 P18505 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA5 P31644 1/20 0.38
GABRA3 P34903 1/20 0.38
GABRA2 P47869 1/20 0.38
GABRB2 P47870 1/20 0.38
GABRA4 P48169 1/20 0.38
GABRE P78334 1/20 0.38
GABRA6 Q16445 1/20 0.38
GABRG1 Q8N1C3 1/20 0.38
GABRG3 Q99928 1/20 0.38
GABRQ Q9UN88 1/20 0.38
IKBKE Q14164 1/20 0.38
TBK1 Q9UHD2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19231770 0.79 CYP2D6 (0.58) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL19231767 0.78 LMNA (0.42) PIK3CAMTORCYP2D6GHSR
SCHEMBL1820769 0.76 HRH3 (0.56) PIK3CAMTORHRH3
Hydrochloric Acid SCHEMBL1126829 0.75 HRH3 (0.54) PIK3CAMTORHRH3
SCHEMBL19231689 0.74 GHSR (0.40) CYP2D6GHSR
SCHEMBL31416731 0.74 TLR8 (0.38) TLR8TLR7PIK3CAMTORKCNH2
SCHEMBL1035345 0.74 ALDH1A1 (0.56) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL17055000 0.73 HDAC4 (0.39) PIK3CAMTORCHRNB2CHRNA4
SCHEMBL20509326 0.73 TLR8 (0.37) TLR8TLR7KCNH2MCHR1HRH3
SCHEMBL19231685 0.72 LMNA (0.42) PIK3CAMTORHRH3CYP2D6GHSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8969335-B2 Benzonitrile derivatives as kinase inhibitors MERCK PATENT GMBH (DE) 2015-03-03 US disclosed
US-20140228340-A1 BENZONITRILE DERIVATIVES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2014-08-14 US disclosed
WO-2013034238-A1 BENZONITRILE DERIVATIVES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2013-03-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140228340-A1 BENZONITRILE DERIVATIVES AS KINASE INHIBITORS TBK1, NFKBIA, IKBKG TLR8 1282/4885TLR7 978/4885GABRP 2459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.